SNIPR has research findings published in Nature Biotechnology

Scientific PublicationsPress Releases

May 4

Written By Christian Mygind

SNIPR's data on first clinical drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology.

Press release

Research paper

Christian Mygind

Precedential US Federal Court Decision Hands SNIPR a win in patent appeal over Rockefeller University for CRISPR-Cas microbial gene editing

SNIPR Launches A Non-Profit Patent Licensing Program To Enable The Field of CRISPR Editing in Prokaryotes